Gerben Zijlstra will be giving a lecture at Single-Use Event 2024: End-to-End Solutions for Process Intensification

We are very excited to welcome Gerben Zijlsta back to Single-Use Event this year. Zijlstra will be be giving a lecture about End-to-End Solutions for Process Intensification (PI).

About the lecture

End-to-End Solutions for Process Intensification (PI): Expedite and De-risk implementation of early-stage PI Manufacturing Capacity with Sartorius ProcessGo

With Process Intensification industry strives for more efficient manufacturing with lower costs of goods and lower (environmental) footprint. In this presentation, they demonstrate how to implement advanced PI technologies with minimal risk and maximal learning from established best practices through leveraging the know-how and technologies from state-of-the-art industry suppliers.

Sartorius ProcessGo, which represent standardized, yet flexible, End-to-End PI process solutions, are a solid foundation to build your PI process strategies with the latest technologies and automation strategies. And they can be delivered rapidly, at affordable pricing, while have fully secured supply chains due to functional standardization. As such the need for (highly) customized solutions, which are not only more expensive, but also create future supply chain risks, is avoided.

About the speaker

Gerben Zijlstra is a regular speaker on process intensification, process integration and continuous biomanufacturing. He received his Ph.D. from the University of Wageningen (The Netherlands) in the field of process integration in animal cell culture. He has worked for more than 20 years in the CDMO industry and has been involved in the development of several commercial Bio-therapeutics, as well as innovation projects. He was one of the early adopters of Single Use bioreactors and is the first inventor of the Concentrated Fed-Batch - XD® technology, amongst others licensed by Amgen. Subsequently, as a Consultant, Gerben has been working on several Continuous BioManufacturing as well as Gene Therapy projects. 

Since end of 2016 he has joined the Sartorius Stedim Biotech Marketing Team, where he currently holds a position as External Collaboration Manager for Intensified and Continuous BioManufacturing.

Collaboration Sartorius and Enzene Biosciences Ltd

Enzene is a company focused on impacting global healthcare by delivering trusted and affordable medicine for a better quality of life. They are doing this by innovating new solutions for continuous biomanufacturing. Biomanufacturing is a complicated process by nature, and it’s made more complex by the unique regulatory challenges it faces. With help from Sartorius, Enzene is working to develop a platform for innovation in India.

Today, Enzene and Sartorius are continuing their collaboration in an ongoing effort to develop therapeutics that are as accessible as possible to patients in countries like India, as well as the global market.